A 6-week repeated intranasal dose toxicity study of TTA-121, a novel oxytocin nasal spray, in rats

Autism spectrum disorder (ASD) is a highly prevalent neurodevelopmental disorder. Although there is no established treatment for the core symptoms of ASD, recent research has indicated a potentially therapeutic effect of intranasally administered oxytocin. TTA-121 is a novel oxytocin nasal spray wit...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Fundamental Toxicological Sciences 2019, Vol.6(7), pp.259-268
Hauptverfasser:	Namekawa, Junichi, Matsumoto, Emi, Kaneko, Hideshi, Shimomoto, Takasumi, Okamura, Takayuki, Oshikata, Takafumi, Renne, Roger A., Miura, Daishiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Autism spectrum disorder Novel nasal spray Oxytocin Repeated dose toxicity TTA-121
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!